Antunes L - Search Results

1

Distant Metastases in Uterine Leiomyosarcomas: The Wide Variety of Body Sites and Time Intervals to Metastatic Relapse.

Bartosch C, Afonso M, Pires-Luís AS, Galaghar A, Guimarães M, Antunes L, Lopes JM. Bartosch C, et al. Among authors: antunes l. Int J Gynecol Pathol. 2017 Jan;36(1):31-41. doi: 10.1097/PGP.0000000000000284. Int J Gynecol Pathol. 2017. PMID: 27015437 Review.

2

Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication.

Pires-Luís AS, Vieira-Coimbra M, Vieira FQ, Costa-Pinheiro P, Silva-Santos R, Dias PC, Antunes L, Lobo F, Oliveira J, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. Pires-Luís AS, et al. Among authors: antunes l. Epigenetics. 2015;10(11):1033-43. doi: 10.1080/15592294.2015.1103578. Epigenetics. 2015. PMID: 26488939 Free PMC article.

3

Prognostic significance of MST1R dysregulation in renal cell tumors.

Pires-Luís AS, Vieira-Coimbra M, Ferreira MJ, Ramalho-Carvalho J, Costa-Pinheiro P, Antunes L, Dias PC, Lobo F, Oliveira J, Graça I, Henrique R, Jerónimo C. Pires-Luís AS, et al. Among authors: antunes l. Am J Cancer Res. 2016 Aug 1;6(8):1799-811. eCollection 2016. Am J Cancer Res. 2016. PMID: 27648366 Free PMC article.

4

Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel.

Pires-Luís AS, Costa-Pinheiro P, Ferreira MJ, Antunes L, Lobo F, Oliveira J, Henrique R, Jerónimo C. Pires-Luís AS, et al. Among authors: antunes l. J Transl Med. 2017 Jun 29;15(1):149. doi: 10.1186/s12967-017-1248-y. J Transl Med. 2017. PMID: 28662726 Free PMC article.

5

SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization.

Ferreira MJ, Pires-Luís AS, Vieira-Coimbra M, Costa-Pinheiro P, Antunes L, Dias PC, Lobo F, Oliveira J, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. Ferreira MJ, et al. Among authors: antunes l. Epigenetics. 2017;12(12):1057-1064. doi: 10.1080/15592294.2017.1385685. Epub 2018 Jan 22. Epigenetics. 2017. PMID: 29099276 Free PMC article.

6

The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: a cost estimate with real-world data.

Borges A, Pereira F, Redondo P, Antunes L, Vieira C, Antunes P, Bento MJ, Sousa S, Lopes JM, Rocha-Gonçalves F, de Sousa JA, Pereira DS, Borges M. Borges A, et al. Among authors: antunes p, antunes l. Health Econ Rev. 2021 Sep 10;11(1):33. doi: 10.1186/s13561-021-00332-0. Health Econ Rev. 2021. PMID: 34505956 Free PMC article.

7

Pertuzumab in Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment for HER2-Positive Breast Cancer.

Vieira C, Borges A, Pereira FF, Antunes P, Redondo P, Antunes L, Lopes JM, Gonçalves FR, Borges M, Bento MJ. Vieira C, et al. Among authors: antunes p, antunes l. J Immunother Precis Oncol. 2022 Dec 13;6(1):1-9. doi: 10.36401/JIPO-22-12. eCollection 2023 Feb. J Immunother Precis Oncol. 2022. PMID: 36751658 Free PMC article.

8

Incidence, time trends and survival patterns of childhood pilocytic astrocytomas in Southern-Eastern Europe and SEER, US.

Georgakis MK, Karalexi MA, Kalogirou EI, Ryzhov A, Zborovskaya A, Dimitrova N, Eser S, Antunes L, Sekerija M, Zagar T, Bastos J, Agius D, Florea M, Coza D, Bouka E, Bourgioti C, Dana H, Hatzipantelis E, Moschovi M, Papadopoulos S, Sfakianos G, Papakonstantinou E, Polychronopoulou S, Sgouros S, Stefanaki K, Stiakaki E, Strantzia K, Zountsas B, Pourtsidis A, Patsouris E, Petridou ET. Georgakis MK, et al. Among authors: antunes l. J Neurooncol. 2017 Jan;131(1):163-175. doi: 10.1007/s11060-016-2284-9. Epub 2016 Oct 14. J Neurooncol. 2017. PMID: 27743145

9

Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists.

Lobo J, Costa AL, Vilela-Salgueiro B, Rodrigues Â, Guimarães R, Cantante M, Lopes P, Antunes L, Jerónimo C, Henrique R. Lobo J, et al. Among authors: antunes l. Hum Pathol. 2018 Dec;82:113-124. doi: 10.1016/j.humpath.2018.07.016. Epub 2018 Jul 21. Hum Pathol. 2018. PMID: 30041024

10

E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients.

Lobo J, Petronilho S, Newell AH, Coach J, Harlow G, Cruz A, Lopes P, Antunes L, Bai I, Walker E, Henrique R. Lobo J, et al. Among authors: antunes l. Mod Pathol. 2019 Nov;32(11):1574-1586. doi: 10.1038/s41379-019-0294-9. Epub 2019 Jun 23. Mod Pathol. 2019. PMID: 31231125 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

816 results

Search Page